LLVK is a selective inhibitor of IkappaB phosphorylation. It effectively reduces LPS-induced pro-inflammatory cytokines (IL-1beta, IL-6, TNF-alpha). LLVK shows potential for research in inflammatory bowel disease and rheumatoid arthritis.
Molecular Weight:
471.63
CAS Number:
[798540-36-0]
Formula:
C23H45N5O5
Target:
IkappaB/IKK|||NF-kappaB
TP3859
* VAT and and shipping costs not included. Errors and price changes excepted
